About FAC 2023
The organisation for the 24th joint meeting held by kConFab, ISK, ABCFS, ACCFS, Lifepool and the Family Cancer Clinics of Australia for August - September 2023 is progressing well and we will hold a face-to-face and on-line meeting.
Although the named consortia are funded in very different ways and have no official connections, all groups share a common interest in familial and population based cancer. For example, kConFab recruits families at high genetic risk of breast, ovarian and prostate cancer through Family Cancer Clinics located in every State and Territory of Australia and return our research generated germ-line mutation test results back to family members and the relevant treating FCC. In one sense kConFab is the research arm of the national Family Cancer Clinics. Many of the consortia members are health professionals (medical oncologists, surgeons, genetic counsellors, cancer specialists, research scientists) working in the Family Cancer Clinics and major research institutions through-out Australia and New Zealand.
A joint annual meeting has particular value for the groups mentioned as it provides a forum to develop and discuss new research findings, clinical trials and implementation of technologies about families with multiple cases of breast, ovarian, prostate, endometrial melanoma, sarcoma, leukaemia and colorectal cancers.
FAC 2023 will be hybrid
FAC 2023 will be delivered in a hybrid format, combining an in-person conference experience with an online component.
In-Person attendees will experience all the usual highlights of the FAC meeting, including leading keynote presentations, opportunity to submit abstracts to present an oral or poster presentation, opportunity to attend breakout sessions, networking opportunities and an industry exhibition.
Virtual attendees will be able to view the live-streamed presentations in the plenary sessions and participate in the Q & A. They also have the opportunity to submit abstracts and present an oral or poster presentation.
Topics to be Covered
Themes for the Family Cancer Clinic Day include:
- Genotype-directed therapy and risk mitigation
- Psychosocial aspects of genetic counselling
- Variant curation, case examples, current research and guidelines.
- Haematological malignancies
Themes for the combined clinical, scientific and psychosocial meeting:
- Breast, ovarian, prostate, sarcoma, colorectal cancer, haematological malignancies, paediatric cancer susceptibility/predisposition
- Polygenic Risk Score and cancer risk
- Cancer signatures to direct treatment
- The value of surveillance in changing clinical practice
- Early cancer detection research programs
- Imaging biomarkers of breast cancer risk and response to treatment
- Variant curation and bioinformatics
Daniel Buchanan, The University of Melbourne
Lisa Devereux, The Peter MacCallum Cancer Centre, Melbourne
Jessica Duffy, Wollongong Hospital, NSW
John Hopper, The University of Melbourne
Shuai Li, The University of Melbourne, Melbourne
Tu Ngugen Dumont, Monash University, Melbourne
Sarah O'Sullivan, Genetic Services of Western Australia
Melissa Southey, Monash University, Melbourne
Heather Thorne, The Peter MacCallum Cancer Centre, Melbourne
Rachel Williams, Prince of Wales Hospital, Sydney
Milita Zaheed, Prince of Wales Hospital, Sydney